SanjalHimanshuDesaiMD

Hematology • Minneapolis, MN

Physician

Join to view full profile

Dr. Desai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Desai's full profile

Already have an account?

Office
909 Fulton St SE
Minneapolis, MN 55455
Phone+1 612-625-3600

Education & Training

Government Medical College, SuratClass of 2013
Georgetown University HospitalFellowship, Hematology
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine

Certifications & Licensure

MN State Medical License 2020 - 2025
DC State Medical License 2017 - 2020
MI State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma Start of enrollment: 2024 Aug 01
Not yet recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

3 citations
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova
Blood Advances. 2023-12-12
4 citations
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of re...
Charlotte B Wagner, Ken Boucher, Adrienne Nedved, Ivana N Micallef, Sanjal Desai
Haematologica. 2023-11-01
10 citations
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Sanjal H Desai, Michael A Spinner, Kevin David, Veronika Bachanova, Gaurav Goyal
American Journal of Hematology. 2023-03-01

Abstracts/Posters

Prevalence of Chronic Kidney Disease (CKD) in Lymphoma Survivors
Sanjal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas
Sanjal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Virologic Clearance of Hepatitis C Is Associated with Improved Outcomes in African American Patients with Lymphoma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019